Plasma NFL, GFAP, sTREM2, pTau231, and clinical severity in progressive supranuclear palsy
This study demonstrated the feasibility of using four plasma markers simultaneously to determine PSP disease severity. To verify these findings, longitudinal analyses are necessary.
Authors
- Jee-Young Lee (ORCID: https://orcid.org/0000-0002-9120-2075)
- Bora Jin
- Seungmin Lee (ORCID: https://orcid.org/0000-0001-7760-5524)
- Seoyeon Kim (ORCID: https://orcid.org/0000-0002-2983-8697)
- Su Hyeon Ha (ORCID: https://orcid.org/0000-0003-3981-2308)
- Han-joon Kim
- Heejung Kim
- Jung Hwan Shin
- Ryul Kim
- Beomseok Jeon
Institutions
- Seoul National University (KR)
- Dong-A University Hospital (KR)
- Seoul Metropolitan Government (KR)
- Seoul National University Hospital (KR)
- SNUH SMG-SNU Boramae Medical Center (KR)
- National University College (PR)
- Inha University Hospital (KR)
- Chung-Ang University Hospital (KR)
Publication Details
- Journal
- Journal of Neurology
- Published
- 2025-12-26
- DOI
- https://doi.org/10.1007/s00415-025-13570-7
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Research Foundation
- Ministry of Science and ICT, South Korea